Jpmorgan Chase & Co. - Net Worth and Insider Trading
Jpmorgan Chase & Co. Net Worth
The estimated net worth of Jpmorgan Chase & Co. is at least $219 Million dollars as of 2024-09-29. Jpmorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Hangzhou Tigermed Consulting Co Ltd and owns about 6,275,646 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) stock worth over $219 Million. Details can be seen in Jpmorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jpmorgan Chase & Co. has not made any transactions after 2024-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jpmorgan Chase & Co. owns 1 companies in total, including Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) .
Click here to see the complete history of Jpmorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of Jpmorgan Chase & Co.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:03347 | Hangzhou Tigermed Consulting Co Ltd | 2024-03-15 | 2201 Interest of corporation controlled by you |
Jpmorgan Chase & Co. Latest Holdings Summary
Jpmorgan Chase & Co. currently owns a total of 1 stock. Jpmorgan Chase & Co. owns 6,275,646 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) as of March 15, 2024, with a value of $219 Million.
Latest Holdings of Jpmorgan Chase & Co.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:03347 | Hangzhou Tigermed Consulting Co Ltd | 2024-03-15 | 6,275,646 | 34.95 | 219,333,828 |
Holding Weightings of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, Jpmorgan Chase & Co. has made a total of 146 transactions in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) over the past 5 years, including 5 buys and 8 sells. The most-recent trade in Hangzhou Tigermed Consulting Co Ltd is the acquisition of 211,400 shares on March 15, 2024, which cost Jpmorgan Chase & Co. around $7 Million.
Insider Trading History of Jpmorgan Chase & Co.
- 1
Jpmorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of Jpmorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jpmorgan Chase & Co. is -6.52%. GuruFocus also compares Jpmorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Jpmorgan Chase & Co. within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jpmorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Ownership Network
Jpmorgan Chase & Co. Owned Company Details
What does Hangzhou Tigermed Consulting Co Ltd do?
Who are the key executives at Hangzhou Tigermed Consulting Co Ltd?
Jpmorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Hangzhou Tigermed Consulting Co Ltd. Other key executives at Hangzhou Tigermed Consulting Co Ltd include 2102 Investment manager yi fang da ji jin guan li you xian gong si , 2101 Beneficial owner Sands Capital Management, LLC , and 2201 Interest of corporation controlled by you Sands Capital Management, LP .
Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) Insider Trades Summary
Over the past 18 months, Jpmorgan Chase & Co. made 110 insider transaction in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) with a net sale of 470,919. Other recent insider transactions involving Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) include a net purchase of 614,287 shares made by BlackRock, Inc. , a net sale of 0 shares made by Citigroup Inc. , and a net sale of 0 shares made by Ubs Group Ag .
In summary, during the past 3 months, insiders sold 0 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,186,442 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) were sold and 6,491,910 shares were bought by its insiders, resulting in a net purchase of 2,305,468 shares.
Hangzhou Tigermed Consulting Co Ltd (HKSE:03347)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hangzhou Tigermed Consulting Co Ltd Insider Transactions
Jpmorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for Jpmorgan Chase & Co.. Currently GuruFocus does not have mailing address information for Jpmorgan Chase & Co..